Pfizer Inc. #AA# Corporate Credit And Other Ratings Outlook Stable

Stocks and Financial Services Press Releases Tuesday November 29, 2016 09:10
TORONTO--29 Nov--S&P Global Ratings

TORONTO (S&P Global Ratings) Nov. 28, 2016--S&P Global Ratings today affirmed its 'AA' corporate credit and senior unsecured debt ratings, as well as its 'A-1+' short term and commercial paper rating, on Pfizer Inc. The outlook is stable.

New York City-based Pfizer is one of the largest pharmaceutical companies in the world, benefiting from a diverse portfolio of high-margin pharmaceuticals, with particular strengths in neurology, oncology, and vaccines. The portfolio is also backed by an improving product pipeline, bolstered recently by its acquisitions of Medivation Inc. and Anacor Pharmaceuticals Inc., both in 2016, and holds the promise of an ongoing stream of new products. Pfizer's sheer size and diversity also provide a significant competitive advantage. This top-line business risk profile is supported by a modest financial risk profile and policy, highlighted by expected long-term adjusted net leverage of 1.5x-2.0x.

Our stable rating outlook reflects the expectation that cash flow will continue to exceed internal needs and dividends, and enable the company to conduct share repurchases without significant deterioration to its credit measures.

A downgrade would require an unanticipated, dramatic negative industry development, such as price controls, or a shift to a more-aggressive financial policy. We believe that Pfizer currently has limited debt capacity at the current rating, and that any acquisition or share repurchase that would likely lead to leverage being sustained in excess of 2x over the next two years could prompt consideration for a downgrade.

We would consider an upgrade should Pfizer restore its financial leverage to a level that is consistently under 1.5x and refrain from pursuits that could materially affect its credit measures, such as considering a potential breakup of the company (which it has contemplated in the recent past).

Latest Press Release

WHA Industrial Development Signs Double Deal with Chinese Investor GESAC for Land Purchase and Ready Built Factory Lease

Golden Egret Cement Carbide (Thailand) Co., Ltd. (GESAC) has signed a double agreement for the purchase of 56 rai of land and the 3-year lease of a 4,700 sq m Ready-Built-Factory (RBF) at WHA Eastern Seaboard Industrial Estate 1 (WHA ESIE 1). WHA...

Bangkok Bank approved that an interim dividend be paid at the rate of Baht 2.00 per ordinary share

Bangkok Bank approved that an interim dividend from the profit of the operations for the first half of the year 2019 be paid on September 20, 2019 at the rate of Baht 2.00 per ordinary share. Bangkok Bank President Chartsiri Sophonpanich said the Board...

GoComet raises SGD3 million in Series A Round Led by Leo Capital

GoComet today announced that it has raised SGD3 million in a Series A round led by Leo Capital, alongside SGInnovate and August One, with participation from existing investor,India Quotient. Headquartered in Singapore, GoComet also operates in India,...

Fitch Rates PTT Global Chemical#s Debentures #AA+(tha)#

Fitch Ratings (Thailand) has assigned a National Long-Term Rating of 'AA+(tha)' to PTT Global Chemical Public Company Limited's (PTTGC, AA+(tha)/Stable) new senior unsecured debentures. The debentures of up to THB10 billion will be issued in three...

LGT reports strong net asset inflows and further business expansion in first half of 2019

LGT, the international private banking and asset management group owned by the Princely House of Liechtenstein, achieved a group profit of CHF 155.6 million and further expanded its client business in the first half of 2019. The results reflect solid...

Related Topics